Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Quipt Home Medical Corp (QIPT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: QIPT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $3.6
1 Year Target Price $3.6
| 3 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -62.66% | Avg. Invested days 21 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 106.08M USD | Price to earnings Ratio - | 1Y Target Price 3.6 |
Price to earnings Ratio - | 1Y Target Price 3.6 | ||
Volume (30-day avg) 5 | Beta 0.28 | 52 Weeks Range 1.35 - 3.27 | Updated Date 10/17/2025 |
52 Weeks Range 1.35 - 3.27 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.24 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.23% | Operating Margin (TTM) -4.41% |
Management Effectiveness
Return on Assets (TTM) -1.04% | Return on Equity (TTM) -9.51% |
Valuation
Trailing PE - | Forward PE 56.82 | Enterprise Value 195290817 | Price to Sales(TTM) 0.45 |
Enterprise Value 195290817 | Price to Sales(TTM) 0.45 | ||
Enterprise Value to Revenue 0.82 | Enterprise Value to EBITDA 4.09 | Shares Outstanding 43443972 | Shares Floating 34533179 |
Shares Outstanding 43443972 | Shares Floating 34533179 | ||
Percent Insiders 15.27 | Percent Institutions 48.18 |
Upturn AI SWOT
Quipt Home Medical Corp
Company Overview
History and Background
Quipt Home Medical Corp. was founded in 2015. It has grown through acquisitions and organic growth, focusing on providing home medical equipment and respiratory care services. The company aims to improve patient outcomes and reduce healthcare costs.
Core Business Areas
- Respiratory Equipment: Provision of oxygen concentrators, ventilators, BiPAP, and CPAP devices for patients with respiratory conditions such as COPD, sleep apnea, and other respiratory disorders.
- Home Medical Equipment (HME): Supply of durable medical equipment (DME) including wheelchairs, walkers, hospital beds, and other mobility and support equipment for home use.
- Home Sleep Testing (HST): Administering and interpreting home-based sleep studies to identify and diagnose sleep disorders.
Leadership and Structure
The leadership team includes Greg Crawford (Chairman and CEO) and Hardik Shah (CFO). The organizational structure is designed to support regional operations and centralized support functions like billing and compliance.
Top Products and Market Share
Key Offerings
- CPAP/BiPAP Machines: These are used for sleep apnea treatment. Quipt provides equipment and ongoing support. Market share data is not publicly available at a granular level. Competitors include ResMed, Philips Respironics (although Philips had recalls) and Fisher & Paykel Healthcare. Revenue attributed to this product stream is a significant portion of their respiratory revenue.
- Oxygen Concentrators: Used for patients with COPD and other respiratory ailments needing supplemental oxygen at home. Market share data is not publicly available at a granular level. Competitors include Inogen, Invacare, and CAIRE. Revenue attributed to this product stream is a significant portion of their respiratory revenue.
- Mobility Equipment: Includes wheelchairs, walkers, and other devices to assist patients with mobility issues. Market data is highly fragmented. Competitors include Medline Industries, Drive DeVilbiss Healthcare, and Invacare. Market share data is not publicly available at a granular level.
Market Dynamics
Industry Overview
The home medical equipment industry is driven by an aging population, increasing prevalence of chronic diseases, and a shift towards home-based healthcare. The industry is highly regulated and subject to reimbursement pressures.
Positioning
Quipt Home Medical Corp positions itself as a provider of comprehensive home medical equipment and respiratory care services, focusing on customer service and clinical expertise. They aim to leverage technology to improve efficiency and patient outcomes.
Total Addressable Market (TAM)
The global home healthcare market is expected to reach hundreds of billions of dollars. Quipt is positioned to capture a segment of the respiratory and durable medical equipment portion of this market. The TAM is fragmented geographically and by product category.
Upturn SWOT Analysis
Strengths
- Strong regional presence
- Comprehensive product and service offerings
- Focus on respiratory care
- Experienced management team
- Acquisition expertise
Weaknesses
- Dependence on reimbursement rates
- Integration risks from acquisitions
- Competition from larger players
- Geographic concentration in some regions
Opportunities
- Expanding into new geographic markets
- Increasing penetration of existing markets
- Acquiring smaller competitors
- Developing new products and services
- Growing demand for home healthcare
Threats
- Changes in reimbursement policies
- Increased competition
- Product recalls
- Economic downturn
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- AMN Healthcare Services Inc. (AMN)
- AdaptHealth Corp. (AHCO)
- LHC Group (LHCG)
Competitive Landscape
Quipt is a smaller player compared to some of its larger competitors. Its advantages include its focus on respiratory care and its acquisition strategy. Its disadvantages include its smaller scale and dependence on reimbursement rates.
Major Acquisitions
NorCal Respiratory Services
- Year: 2022
- Acquisition Price (USD millions): 6.5
- Strategic Rationale: Expanded Quipt's presence in Northern California and added respiratory therapy expertise.
Medequip Biomedical
- Year: 2023
- Acquisition Price (USD millions): 4
- Strategic Rationale: Expanded market share
Growth Trajectory and Initiatives
Historical Growth: Quipt has experienced significant growth in recent years, primarily through acquisitions and organic growth in its core markets.
Future Projections: Analyst estimates project continued revenue growth driven by the aging population and demand for home healthcare services. Profitability is expected to improve as the company realizes synergies from acquisitions.
Recent Initiatives: Recent initiatives include expanding into new markets, integrating acquired companies, and investing in technology to improve efficiency.
Summary
Quipt Home Medical Corp. is a growing player in the home medical equipment and respiratory care market, driven by acquisitions and organic growth. The company's focus on respiratory care and customer service provides a competitive advantage. However, the company faces risks related to reimbursement rates, competition, and integration of acquisitions. Future growth will depend on its ability to execute its acquisition strategy and manage costs effectively.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC filings
- Analyst reports
- Industry publications
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share data is based on estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Quipt Home Medical Corp
Exchange NASDAQ | Headquaters Wilder, KY, United States | ||
IPO Launch date 2021-05-27 | Chairman, President & CEO Mr. Gregory J. Crawford | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 1150 | Website https://quipthomemedical.com |
Full time employees 1150 | Website https://quipthomemedical.com | ||
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.